Tracy Morris joined Veracyte in April 2020 as Vice President, Corporate Communications and Investor Relations. In this role, she works in tandem with the Chief Executive Officer and executive team to communicate the company’s strategic vision and value proposition to investors and other audiences and ensures that the market-leading company’s brand is articulated in product and other communications. Ms. Morris has over 25 years of experience in healthcare communications and public relations. Prior to joining Veracyte, she served as a strategic communications consultant to the company for nearly 10 years, as well as to other diagnostics innovators, ranging from start-ups to Fortune 500 companies. Earlier in her career, Ms. Morris was Director of U.S. Marketing Communications for Digene Corporation, a molecular diagnostics company that pioneered HPV testing in cervical cancer early detection. She previously served as Senior Vice President of Healy Communications, a Chicago-based public relations firm (acquired by Finn Partners), and began her career at Edelman Public Relations in Washington, DC. Ms. Morris holds a B.A. in English from the College of William and Mary in Williamsburg, Virginia.
Vice President, Corporate Communications and Investor Relations